PDL Biopharma
PDLI
#8057
Rank
โ‚ฌ0.24 B
Marketcap
2,11ย โ‚ฌ
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Market capitalization of PDL Biopharma (PDLI)

Last known market cap: โ‚ฌ0.24 Billion

As of January 2026 PDL Biopharma has a market cap of โ‚ฌ0.24 Billion. This makes PDL Biopharma the world's 8057th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PDL Biopharma from 2001 to 2021

End of year Market Cap

Year Marketcap Change
2021โ‚ฌ0.24 B8.61%
2020โ‚ฌ0.22 B-36.3%
2019โ‚ฌ0.36 B4.05%
2018โ‚ฌ0.34 B-1.81%
2017โ‚ฌ0.35 B5.64%
2016โ‚ฌ0.33 B-37.27%
2015โ‚ฌ0.53 B-48.27%
2014โ‚ฌ1.02 B20.22%
2013โ‚ฌ0.85 B14.93%
2012โ‚ฌ0.74 B11.46%
2011โ‚ฌ0.66 B2.07%
2010โ‚ฌ0.65 B14.28%
2009โ‚ฌ0.57 B8.33%
2008โ‚ฌ0.52 B-62.55%
2007โ‚ฌ1.41 B-19.63%
2006โ‚ฌ1.75 B-34.71%
2005โ‚ฌ2.68 B84.15%
2004โ‚ฌ1.45 B9.37%
2003โ‚ฌ1.33 B84.08%
2002โ‚ฌ0.72 B-78.03%
2001โ‚ฌ3.29 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Compugen
CGEN
โ‚ฌ0.15 B-36.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ149.23 B 61,686.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ0.67 B 178.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ821.17 B 339,875.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ0.12 B-47.94%๐Ÿ‡บ๐Ÿ‡ธ USA